255 related articles for article (PubMed ID: 25829248)
1. Comparisons of hospitalization rates among younger atrial fibrillation patients receiving different antiarrhythmic drugs.
Allen LaPointe NM; Dai D; Thomas L; Piccini JP; Peterson ED; Al-Khatib SM
Circ Cardiovasc Qual Outcomes; 2015 May; 8(3):292-300. PubMed ID: 25829248
[TBL] [Abstract][Full Text] [Related]
2. Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease.
Allen LaPointe NM; Dai D; Thomas L; Piccini JP; Peterson ED; Al-Khatib SM
Am J Cardiol; 2015 Feb; 115(3):316-22. PubMed ID: 25491240
[TBL] [Abstract][Full Text] [Related]
3. The effect of antiarrhythmic medications on the risk of cardiovascular outcomes in patients with atrial fibrillation and coronary artery disease.
Wang SR; Huang KC; Lin TT; Chuang SL; Yang YY; Wu CK; Lin LY
Int J Cardiol; 2024 Aug; 409():132198. PubMed ID: 38782070
[TBL] [Abstract][Full Text] [Related]
4. Comparative effectiveness of antiarrhythmic drugs for rhythm control of atrial fibrillation.
Qin D; Leef G; Alam MB; Rattan R; Munir MB; Patel D; Khattak F; Adelstein E; Jain SK; Saba S
J Cardiol; 2016 May; 67(5):471-6. PubMed ID: 26233885
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of dronedarone in patients previously treated with other antiarrhythmic agents.
Guerra F; Hohnloser SH; Kowey PR; Crijns HJ; Aliot EM; Radzik D; Roy D; Connolly S; Capucci A
Clin Cardiol; 2014 Dec; 37(12):717-24. PubMed ID: 25470298
[TBL] [Abstract][Full Text] [Related]
6. Real-World Comparison of Classes IC and III Antiarrhythmic Drugs as an Initial Rhythm Control Strategy in Newly Diagnosed Atrial Fibrillation: From the TREAT-AF Study.
Kipp R; Askari M; Fan J; Field ME; Turakhia MP
JACC Clin Electrophysiol; 2019 Feb; 5(2):231-241. PubMed ID: 30784696
[TBL] [Abstract][Full Text] [Related]
7. One-year treatment persistence and potential adverse events among patients with atrial fibrillation treated with amiodarone or sotalol: a retrospective claims database analysis.
Kim MH; Smith PJ; Jhaveri M; Lin J; Klingman D
Clin Ther; 2011 Nov; 33(11):1668-1681.e1. PubMed ID: 22108302
[TBL] [Abstract][Full Text] [Related]
8. Design and rationale of a randomized study to compare amiodarone and Class IC anti-arrhythmic drugs in terms of atrial fibrillation treatment efficacy in patients paced for sinus node disease: the PITAGORA trial.
Gulizia M; Mangiameli S; Chiarandà G; Spadola V; Di Giovanni N; Colletti A; Bulla V; Circo A; Pensabene O; Vasquez L; Vaccaro I; Grammatico A;
Europace; 2006 Apr; 8(4):302-5. PubMed ID: 16627459
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses.
Saksena S; Slee A; Waldo AL; Freemantle N; Reynolds M; Rosenberg Y; Rathod S; Grant S; Thomas E; Wyse DG
J Am Coll Cardiol; 2011 Nov; 58(19):1975-85. PubMed ID: 22032709
[TBL] [Abstract][Full Text] [Related]
10. An individual patient-based meta-analysis of the effects of dronedarone in patients with atrial fibrillation.
Hohnloser SH; Connolly SJ; John Camm A; Halperin JL; Radzik D
Europace; 2014 Aug; 16(8):1117-24. PubMed ID: 24728270
[TBL] [Abstract][Full Text] [Related]
11. A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial.
Gulizia M; Mangiameli S; Orazi S; Chiarandà G; Piccione G; Di Giovanni N; Colletti A; Pensabene O; Lisi F; Vasquez L; Grammatico A; Boriani G;
Am Heart J; 2008 Jan; 155(1):100-7, 107.e1. PubMed ID: 18082498
[TBL] [Abstract][Full Text] [Related]
12. Outcomes Associated with Dronedarone Use in Patients with Atrial Fibrillation.
Goehring EL; Bohn RL; Pezzullo J; Tave AK; Jones JK; Bozzi S; Tamayo RCSG; Sicignano N; Naccarelli GV
Am J Cardiol; 2020 Nov; 135():77-83. PubMed ID: 32861738
[TBL] [Abstract][Full Text] [Related]
13. Ventricular arrhythmia and death among atrial fibrillation patients using anti-arrhythmic drugs.
Friberg L
Am Heart J; 2018 Nov; 205():118-127. PubMed ID: 30236980
[TBL] [Abstract][Full Text] [Related]
14. Limited duration of antiarrhythmic drug use for newly diagnosed atrial fibrillation in a nationwide population under age 65.
D'Angelo RN; Rahman M; Khanna R; Yeh RW; Goldstein L; Yadalam S; Kalsekar I; Tung P; Zimetbaum PJ
J Cardiovasc Electrophysiol; 2021 Jun; 32(6):1529-1537. PubMed ID: 33760297
[TBL] [Abstract][Full Text] [Related]
15. International cohort study on the effectiveness of dronedarone and other antiarrhythmic drugs for atrial fibrillation in real-world practice (EFFECT-AF).
Khachatryan A; Merino JL; de Abajo FJ; Botto GL; Kirchhof P; Breithardt G; Stambler B; Abenhaim L; Grimaldi-Bensouda L
Europace; 2022 Jul; 24(6):899-909. PubMed ID: 34792111
[TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation.
Frommeyer G; Milberg P; Uphaus T; Kaiser D; Kaese S; Breithardt G; Eckardt L
Cardiovasc Ther; 2013 Dec; 31(6):e63-71. PubMed ID: 23647657
[TBL] [Abstract][Full Text] [Related]
17. Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial.
Steinberg BA; Hellkamp AS; Lokhnygina Y; Halperin JL; Breithardt G; Passman R; Hankey GJ; Patel MR; Becker RC; Singer DE; Hacke W; Berkowitz SD; Nessel CC; Mahaffey KW; Fox KA; Califf RM; Piccini JP;
Heart Rhythm; 2014 Jun; 11(6):925-32. PubMed ID: 24833235
[TBL] [Abstract][Full Text] [Related]
18. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).
Page RL; Connolly SJ; Crijns HJ; van Eickels M; Gaudin C; Torp-Pedersen C; Hohnloser SH;
Am J Cardiol; 2011 Apr; 107(7):1019-22. PubMed ID: 21296333
[TBL] [Abstract][Full Text] [Related]
19. Guideline-Concordant Antiarrhythmic Drug Use in the Get With The Guidelines-Atrial Fibrillation Registry.
Field ME; Holmes DN; Page RL; Fonarow GC; Matsouaka RA; Turakhia MP; Lewis WR; Piccini JP;
Circ Arrhythm Electrophysiol; 2021 Feb; 14(2):e008961. PubMed ID: 33419385
[TBL] [Abstract][Full Text] [Related]
20. Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial.
Wong CK; White HD; Wilcox RG; Criger DA; Califf RM; Topol EJ; Ohman EM
Card Electrophysiol Rev; 2003 Sep; 7(3):201-7. PubMed ID: 14739713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
